Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligonucleotide sequences required for natural killer cell activation.

E Kuramoto1, O Yano, Y Kimura

  • 1Mitsui Pharmaceuticals, Inc., Institute of Biological Science, Chiba.

Japanese Journal of Cancer Research : Gann
|November 1, 1992
PubMed
Summary

Certain 30-mer oligonucleotides with specific palindromic sequences, including 5'-CG-3', can induce interferon and enhance natural killer cell activity. The strongest immune response was observed with a 10-mer palindrome and additional oligoguanylate sequences.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced Autophagy in Aged Trigeminal Neurons Causes Amyloid β Diffusion.

Journal of dental research·2023
Same author

Ascending parabrachio-thalamo-striatal pathways: potential circuits for integration of gustatory and oral motor functions.

Neuroscience·2015
Same author

Changes in the Burgers vector of perfect dislocation loops without contact with the external dislocations.

Physical review letters·2006
Same author

Fermi surface of nanocrystalline embedded particles in materials: bcc Cu in Fe.

Physical review letters·2001
Same author

Comparison of glucokinase activities in the peripheral leukocytes between dogs and cats.

Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology·1998
Same author

A comparison of the activities of certain enzymes related to energy metabolism in leukocytes in dogs and cats.

Veterinary research communications·1998

Area of Science:

  • Immunology
  • Molecular Biology
  • Oligonucleotide Therapeutics

Background:

  • Previous research demonstrated that specific 30-mer single-stranded oligodeoxyribonucleotides (oligonucleotides) with 6-mer palindromic sequences induce interferon-alpha and -gamma, and enhance natural killer (NK) cell activity.
  • The precise sequence-activity relationship governing these immune-modulating effects remained to be fully elucidated.

Purpose of the Study:

  • To comprehensively investigate the relationship between the sequence composition of 30-mer oligonucleotides and their ability to induce interferon and enhance NK cell activity.
  • To identify critical sequence motifs and structural features responsible for the observed biological effects.

Main Methods:

  • Synthesis and testing of a series of 30-mer single-stranded oligodeoxyribonucleotides with varying palindromic sequences and lengths.

Related Experiment Videos

  • Assay of interferon-alpha and -gamma induction in response to oligonucleotide treatment.
  • Measurement of natural killer cell activity enhancement.

    • Main Results:

    • Oligonucleotide-induced immune activity is critically dependent on the presence of specific palindromic sequences, notably those containing the 5 earby-CG-3 earby motif.
    • The size and number of palindromic sequences, as well as flanking (extra-palindromic) sequences, significantly influence the magnitude of the immune response.
    • An oligonucleotide featuring a 10-mer palindrome and additional oligoguanylate sequences exhibited the most potent interferon induction and NK cell activity enhancement among those tested.

    Conclusions:

    • The sequence and structural configuration of 30-mer oligonucleotides are crucial determinants of their immunomodulatory potential.
    • The 5 earby-CG-3 earby motif within palindromic sequences is a key element for interferon induction and NK cell activation.
    • Optimized oligonucleotide design, incorporating specific palindromes and oligoguanylate repeats, can lead to enhanced therapeutic immune responses.